Ray Dingledine - Publications

Emory University, Atlanta, GA 
epilepsy, glutamate receptors

183 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Alemán-Ruiz C, Wang W, Dingledine R, Varvel NH. Pharmacological inhibition of the inflammatory receptor CCR2 relieves the early deleterious consequences of status epilepticus. Scientific Reports. 13: 5651. PMID 37024553 DOI: 10.1038/s41598-023-32752-9  0.742
2023 Harris LD, Regan MC, Myers SJ, Nocilla KA, Akins NS, Tahirovic YA, Wilson LJ, Dingledine R, Furukawa H, Traynelis SF, Liotta DC. Novel GluN2B-Selective NMDA Receptor Negative Allosteric Modulator Possesses Intrinsic Analgesic Properties and Enhances Analgesia of Morphine in a Rodent Tail Flick Pain Model. Acs Chemical Neuroscience. PMID 36779874 DOI: 10.1021/acschemneuro.2c00779  0.495
2023 Zaczek R, Traynelis SF, Dingledine R, Koszalka GW, Laskowitz DT. Phase 1 Clinical Results for NP10679, a pH-sensitive GluN2B-selective N-methyl-d-aspartate Receptor Inhibitor. Clinical Pharmacology in Drug Development. PMID 36642931 DOI: 10.1002/cpdd.1217  0.52
2020 Jiang C, Caskurlu A, Ganesh T, Dingledine R. Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammation. Brain, Behavior, & Immunity - Health. 8: 100132. PMID 34589882 DOI: 10.1016/j.bbih.2020.100132  0.776
2020 Jiang C, Amaradhi R, Ganesh T, Dingledine R. An Agonist Dependent Allosteric Antagonist of Prostaglandin EP2 Receptors. Acs Chemical Neuroscience. PMID 32324375 DOI: 10.1021/Acschemneuro.0C00078  0.809
2020 Rojas A, Wang J, Glover A, Dingledine R. Urethane attenuates early neuropathology of diisopropylfluorophosphate-induced status epilepticus in rats. Neurobiology of Disease. 104863. PMID 32283202 DOI: 10.1016/J.Nbd.2020.104863  0.595
2020 Amaradhi R, Banik A, Mohammed S, Patro V, Rojas A, Wang W, Motati DR, Dingledine R, Ganesh T. Potent, selective, water soluble, brain-permeable EP2 receptor antagonist for use in central nervous system disease models. Journal of Medicinal Chemistry. PMID 31904232 DOI: 10.1021/Acs.Jmedchem.9B01218  0.81
2020 Jiang C, Amaradhi R, Ganesh T, Dingledine R. A Noncompetitive and Selective Prostaglandin EP2 Antagonist with Anti‐inflammatory Property The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.00241  0.775
2019 Khan N, Schoenike B, Basu T, Grabenstatter H, Rodriguez G, Sindic C, Johnson M, Wallace E, Maganti R, Dingledine R, Roopra A. A systems approach identifies Enhancer of Zeste Homolog 2 (EZH2) as a protective factor in epilepsy. Plos One. 14: e0226733. PMID 31891591 DOI: 10.1371/Journal.Pone.0226733  0.677
2019 Rojas A, Banik A, Chen D, Flood K, Ganesh T, Dingledine R. A novel microglia cell line expressing the human EP2 receptor. Acs Chemical Neuroscience. PMID 31469538 DOI: 10.1021/Acschemneuro.9B00311  0.809
2019 Manji Z, Rojas A, Wang W, Dingledine R, Varvel NH, Ganesh N. 5xFAD Mice Display Sex-Dependent Inflammatory Gene Induction During the Prodromal Stage of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31322556 DOI: 10.3233/Jad-180678  0.765
2019 Rojas A, Ganesh T, Wang W, Wang J, Dingledine R. A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition. Neurobiology of Disease. PMID 30818067 DOI: 10.1016/J.Nbd.2019.02.010  0.77
2019 Jiang J, Yu Y, Kinjo E, Du Y, Nguyen H, Dingledine R. Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury. Neuropharmacology. PMID 30763657 DOI: 10.1016/J.Neuropharm.2019.02.011  0.719
2019 Taraschenko O, Fox HS, Pittock SJ, Zekeridou A, Gafurova M, Eldridge E, Liu J, Dravid SM, Dingledine R. A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis. Epilepsia. PMID 30740690 DOI: 10.1111/Epi.14662  0.794
2018 Rojas A, Chen D, Ganesh T, Varvel NH, Dingledine R. The COX-2/prostanoid signaling cascades in seizure disorders. Expert Opinion On Therapeutic Targets. PMID 30484341 DOI: 10.1080/14728222.2019.1554056  0.818
2018 Ganesh T, Banik A, Dingledine R, Wang W, Amaradhi R. Peripherally restricted, highly potent, selective, aqueous-soluble EP2 antagonist with anti-inflammatory properties. Molecular Pharmaceutics. PMID 30398879 DOI: 10.1021/Acs.Molpharmaceut.8B00764  0.801
2018 Rojas A, Wang W, Glover A, Manji Z, Fu Y, Dingledine R. Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model. Eneuro. 5. PMID 29766039 DOI: 10.1523/ENEURO.0070-18.2018  0.791
2018 Jiang J, Van TM, Ganesh T, Dingledine R. Discovery of 2-Piperidinyl Phenyl Benzamides and Trisubstituted Pyrimidines as Positive Allosteric Modulators of the Prostaglandin Receptor EP2. Acs Chemical Neuroscience. PMID 29292987 DOI: 10.1021/Acschemneuro.7B00486  0.806
2017 Klein P, Dingledine R, Aronica E, Bernard C, Blümcke I, Boison D, Brodie MJ, Brooks-Kayal AR, Engel J, Forcelli PA, Hirsch LJ, Kaminski RM, Klitgaard H, Kobow K, Lowenstein DH, et al. Commonalities in epileptogenic processes from different acute brain insults: Do they translate? Epilepsia. PMID 29247482 DOI: 10.1111/Epi.13965  0.345
2017 Aronica E, Bauer S, Bozzi Y, Caleo M, Dingledine R, Gorter JA, Henshall DC, Kaufer D, Koh S, Löscher W, Louboutin JP, Mishto M, Norwood BA, Palma E, Poulter MO, et al. Neuroinflammatory targets and treatments for epilepsy validated in experimental models. Epilepsia. 58: 27-38. PMID 28675563 DOI: 10.1111/Epi.13783  0.316
2017 Dingledine R, Coulter DA, Fritsch B, Gorter JA, Lelutiu N, McNamara J, Nadler JV, Pitkänen A, Rogawski MA, Skene P, Sloviter RS, Wang Y, Wadman WJ, Wasterlain C, Roopra A. Transcriptional profile of hippocampal dentate granule cells in four rat epilepsy models. Scientific Data. 4: 170061. PMID 28485718 DOI: 10.1038/Sdata.2017.61  0.727
2017 Rojas A, Ganesh T, Walker A, Dingledine R. Ethylatropine bromide as a peripherally-restricted muscarinic antagonist. Acs Chemical Neuroscience. PMID 28044440 DOI: 10.1021/Acschemneuro.6B00334  0.748
2016 Varvel NH, Neher JJ, Bosch A, Wang W, Ransohoff RM, Miller RJ, Dingledine R. Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus. Proceedings of the National Academy of Sciences of the United States of America. PMID 27601660 DOI: 10.1073/Pnas.1604263113  0.742
2016 Rojas A, Ganesh T, Manji Z, O'neill T, Dingledine R. Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats. Neuropharmacology. PMID 27477533 DOI: 10.1016/J.Neuropharm.2016.07.028  0.752
2016 Galanopoulou AS, Wong M, Binder D, Hartman AL, Powell EM, Roopra A, Staba R, Vezzani A, Fureman B, Dingledine R. 2014 Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression. Epilepsy Currents / American Epilepsy Society. 16: 187-91. PMID 27330451 DOI: 10.5698/1535-7511-16.3.187  0.642
2015 Brown JH, Catterall WA, Conn PJ, Cull-Candy SG, Dingledine R, Harden TK, Insel PA, Milligan G, Traynelis SF. The First 50 Years of Molecular Pharmacology. Molecular Pharmacology. 88: 139-40. PMID 25943115 DOI: 10.1124/mol.115.099564  0.617
2015 Fu Y, Yang MS, Jiang J, Ganesh T, Joe E, Dingledine R. EP2 Receptor Signaling Regulates Microglia Death. Molecular Pharmacology. 88: 161-70. PMID 25715797 DOI: 10.1124/Mol.115.098202  0.782
2015 Hassel B, Elsais A, Frøland AS, Taubøll E, Gjerstad L, Quan Y, Dingledine R, Rise F. Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitro. Journal of Neurochemistry. 133: 572-81. PMID 25708447 DOI: 10.1111/Jnc.13079  0.586
2015 Rojas A, Ganesh T, Lelutiu N, Gueorguieva P, Dingledine R. Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus. Neuropharmacology. 93: 15-27. PMID 25656476 DOI: 10.1016/J.Neuropharm.2015.01.017  0.77
2015 Jiang J, Yang MS, Quan Y, Gueorguieva P, Ganesh T, Dingledine R. Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus. Neurobiology of Disease. 76: 126-36. PMID 25600211 DOI: 10.1016/J.Nbd.2014.12.032  0.809
2015 Varvel NH, Jiang J, Dingledine R. Candidate drug targets for prevention or modification of epilepsy. Annual Review of Pharmacology and Toxicology. 55: 229-47. PMID 25196047 DOI: 10.1146/Annurev-Pharmtox-010814-124607  0.79
2014 Dingledine R, Varvel NH, Dudek FE. When and how do seizures kill neurons, and is cell death relevant to epileptogenesis? Advances in Experimental Medicine and Biology. 813: 109-22. PMID 25012371 DOI: 10.1007/978-94-017-8914-1_9  0.735
2014 Rojas A, Gueorguieva P, Lelutiu N, Quan Y, Shaw R, Dingledine R. The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus. Neurobiology of Disease. 70: 74-89. PMID 24952362 DOI: 10.1016/J.Nbd.2014.06.004  0.769
2014 Ganesh T, Jiang J, Dingledine R. Development of second generation EP2 antagonists with high selectivity. European Journal of Medicinal Chemistry. 82: 521-35. PMID 24937185 DOI: 10.1016/J.Ejmech.2014.05.076  0.79
2014 Ganesh T, Jiang J, Yang MS, Dingledine R. Lead optimization studies of cinnamic amide EP2 antagonists. Journal of Medicinal Chemistry. 57: 4173-84. PMID 24773616 DOI: 10.1021/Jm5000672  0.782
2014 Rojas A, Jiang J, Ganesh T, Yang MS, Lelutiu N, Gueorguieva P, Dingledine R. Cyclooxygenase-2 in epilepsy. Epilepsia. 55: 17-25. PMID 24446952 DOI: 10.1111/Epi.12461  0.794
2013 Ganesh T, Jiang J, Shashidharamurthy R, Dingledine R. Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists. Acs Medicinal Chemistry Letters. 4: 616-621. PMID 23914286 DOI: 10.1021/Ml400112H  0.761
2013 Jiang J, Dingledine R. Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection. Trends in Pharmacological Sciences. 34: 413-23. PMID 23796953 DOI: 10.1016/J.Tips.2013.05.003  0.665
2013 Quan Y, Jiang J, Dingledine R. EP2 receptor signaling pathways regulate classical activation of microglia. The Journal of Biological Chemistry. 288: 9293-302. PMID 23404506 DOI: 10.1074/Jbc.M113.455816  0.759
2013 Jiang J, Quan Y, Ganesh T, Pouliot WA, Dudek FE, Dingledine R. Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation. Proceedings of the National Academy of Sciences of the United States of America. 110: 3591-6. PMID 23401547 DOI: 10.1073/Pnas.1218498110  0.817
2013 Rojas A, Dingledine R. Ionotropic glutamate receptors: regulation by G-protein-coupled receptors. Molecular Pharmacology. 83: 746-52. PMID 23348498 DOI: 10.1124/Mol.112.083352  0.611
2013 Cox B, Han JS, Dingledine R. Avram Goldstein: the founder of molecular pharmacology. Molecular Pharmacology. 83: 720-2. PMID 23329728 DOI: 10.1124/Mol.112.084640  0.443
2013 Jiang J, Dingledine R. Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation. The Journal of Pharmacology and Experimental Therapeutics. 344: 360-7. PMID 23192657 DOI: 10.1124/Jpet.112.200444  0.654
2013 Rojas A, Wetherington J, Shaw R, Serrano G, Swanger S, Dingledine R. Activation of group I metabotropic glutamate receptors potentiates heteromeric kainate receptors. Molecular Pharmacology. 83: 106-21. PMID 23066089 DOI: 10.1124/Mol.112.081802  0.816
2012 Roopra A, Dingledine R, Hsieh J. Epigenetics and epilepsy. Epilepsia. 53: 2-10. PMID 23216574 DOI: 10.1111/Epi.12030  0.675
2012 Levin JR, Serrano G, Dingledine R. Reduction in delayed mortality and subtle improvement in retrograde memory performance in pilocarpine-treated mice with conditional neuronal deletion of cyclooxygenase-2 gene. Epilepsia. 53: 1411-20. PMID 22780884 DOI: 10.1111/J.1528-1167.2012.03584.X  0.533
2012 Jiang J, Ganesh T, Du Y, Quan Y, Serrano G, Qui M, Speigel I, Rojas A, Lelutiu N, Dingledine R. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2. Proceedings of the National Academy of Sciences of the United States of America. 109: 3149-54. PMID 22323596 DOI: 10.1073/Pnas.1120195109  0.826
2012 Dingledine RJ, Bennett JA. Structure and Function of Ligand-Gated Channels The Cortical Neuron. DOI: 10.1093/acprof:oso/9780195083309.003.0005  0.398
2012 Min J, Du Y, Bondesen B, Revennaugh B, Eimon P, Dingledine R. Use of transgenic zebrafish in a phenotypic screen for angiogenesis inhibitors Chemical Genomics. 225-231. DOI: 10.1017/CBO9781139021500.021  0.751
2011 Serrano GE, Lelutiu N, Rojas A, Cochi S, Shaw R, Makinson CD, Wang D, FitzGerald GA, Dingledine R. Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 14850-60. PMID 22016518 DOI: 10.1523/Jneurosci.3922-11.2011  0.692
2011 Friedman A, Dingledine R. Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia. 52: 33-9. PMID 21542844 DOI: 10.1111/J.1528-1167.2011.03034.X  0.34
2011 Mott DD, Dingledine R. Unraveling the role of zinc in memory. Proceedings of the National Academy of Sciences of the United States of America. 108: 3103-4. PMID 21321213 DOI: 10.1073/pnas.1100323108  0.53
2011 Laezza F, Dingledine R. Induction and expression rules of synaptic plasticity in hippocampal interneurons. Neuropharmacology. 60: 720-9. PMID 21195098 DOI: 10.1016/J.Neuropharm.2010.12.016  0.676
2010 Lau AG, Irier HA, Gu J, Tian D, Ku L, Liu G, Xia M, Fritsch B, Zheng JQ, Dingledine R, Xu B, Lu B, Feng Y. Distinct 3'UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF). Proceedings of the National Academy of Sciences of the United States of America. 107: 15945-50. PMID 20733072 DOI: 10.1073/Pnas.1002929107  0.794
2010 Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacological Reviews. 62: 405-96. PMID 20716669 DOI: 10.1124/Pr.109.002451  0.812
2010 Benveniste M, Wilhelm J, Dingledine RJ, Mott DD. Subunit-dependent modulation of kainate receptors by muscarinic acetylcholine receptors. Brain Research. 1352: 61-9. PMID 20655886 DOI: 10.1016/J.Brainres.2010.07.029  0.756
2010 Jiang J, Ganesh T, Du Y, Thepchatri P, Rojas A, Lewis I, Kurtkaya S, Li L, Qui M, Serrano G, Shaw R, Sun A, Dingledine R. Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor. Proceedings of the National Academy of Sciences of the United States of America. 107: 2307-12. PMID 20080612 DOI: 10.1073/Pnas.0909310107  0.817
2010 Mott DD, Rojas A, Fisher JL, Dingledine RJ, Benveniste M. Subunit-specific desensitization of heteromeric kainate receptors. The Journal of Physiology. 588: 683-700. PMID 20026616 DOI: 10.1113/Jphysiol.2009.185207  0.763
2010 Dingledine R. Glutamatergic mechanisms related to epilepsy: Ionotropic receptors Epilepsia. 51: 15. DOI: 10.1111/j.1528-1167.2010.02801.x  0.451
2009 Thepchatri P, Min J, Ganesh T, Du Y, Lewis I, Kurtkaya S, Prussia A, Li L, Sneed B, Plemper RK, Fu H, Liotta DC, Snyder JP, Dingledine R, Sun A. Cancer and virus leads by HTS, chemical design and SEA data mining. Current Topics in Medicinal Chemistry. 9: 1159-71. PMID 19807668 DOI: 10.2174/156802609789753581  0.604
2009 Irier HA, Quan Y, Yoo J, Dingledine R. Control of glutamate receptor 2 (GluR2) translational initiation by its alternative 3' untranslated regions. Molecular Pharmacology. 76: 1145-9. PMID 19794129 DOI: 10.1124/Mol.109.060343  0.783
2009 Mosley CA, Myers SJ, Murray EE, Santangelo R, Tahirovic YA, Kurtkaya N, Mullasseril P, Yuan H, Lyuboslavsky P, Le P, Wilson LJ, Yepes M, Dingledine R, Traynelis SF, Liotta DC. Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors. Bioorganic & Medicinal Chemistry. 17: 6463-80. PMID 19648014 DOI: 10.1016/J.Bmc.2009.05.085  0.724
2009 Irier HA, Shaw R, Lau A, Feng Y, Dingledine R. Translational regulation of GluR2 mRNAs in rat hippocampus by alternative 3' untranslated regions. Journal of Neurochemistry. 109: 584-94. PMID 19222700 DOI: 10.1111/J.1471-4159.2009.05992.X  0.796
2009 Greene JG, Borges K, Dingledine R. Quantitative transcriptional neuroanatomy of the rat hippocampus: evidence for wide-ranging, pathway-specific heterogeneity among three principal cell layers. Hippocampus. 19: 253-64. PMID 18830999 DOI: 10.1002/Hipo.20502  0.512
2008 Tahirovic YA, Geballe M, Gruszecka-Kowalik E, Myers SJ, Lyuboslavsky P, Le P, French A, Irier H, Choi WB, Easterling K, Yuan H, Wilson LJ, Kotloski R, McNamara JO, Dingledine R, et al. Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists. Journal of Medicinal Chemistry. 51: 5506-21. PMID 18800760 DOI: 10.1021/Jm8002153  0.809
2008 Ganesh T, Min J, Thepchatri P, Du Y, Li L, Lewis I, Wilson L, Fu H, Chiosis G, Dingledine R, Liotta D, Snyder JP, Sun A. Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling. Bioorganic & Medicinal Chemistry. 16: 6903-10. PMID 18571929 DOI: 10.1016/J.Bmc.2008.05.047  0.59
2008 Borges K, Gearing M, Rittling S, Sorensen ES, Kotloski R, Denhardt DT, Dingledine R. Characterization of osteopontin expression and function after status epilepticus. Epilepsia. 49: 1675-85. PMID 18522644 DOI: 10.1111/J.1528-1167.2008.01613.X  0.556
2008 Wetherington J, Serrano G, Dingledine R. Astrocytes in the epileptic brain. Neuron. 58: 168-78. PMID 18439402 DOI: 10.1016/J.Neuron.2008.04.002  0.758
2008 Mott DD, Benveniste M, Dingledine RJ. pH-dependent inhibition of kainate receptors by zinc. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 1659-71. PMID 18272686 DOI: 10.1523/Jneurosci.3567-07.2008  0.742
2007 Bough KJ, Paquet M, Paré JF, Hassel B, Smith Y, Hall RA, Dingledine R. Evidence against enhanced glutamate transport in the anticonvulsant mechanism of the ketogenic diet. Epilepsy Research. 74: 232-6. PMID 17416486 DOI: 10.1016/j.eplepsyres.2007.03.002  0.768
2007 Borges K, Shaw R, Dingledine R. Gene expression changes after seizure preconditioning in the three major hippocampal cell layers. Neurobiology of Disease. 26: 66-77. PMID 17239605 DOI: 10.1016/J.Nbd.2006.12.001  0.576
2006 Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, Shaw R, Smith Y, Geiger JD, Dingledine RJ. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Annals of Neurology. 60: 223-35. PMID 16807920 DOI: 10.1002/Ana.20899  0.78
2006 Borges K, McDermott D, Irier H, Smith Y, Dingledine R. Degeneration and proliferation of astrocytes in the mouse dentate gyrus after pilocarpine-induced status epilepticus. Experimental Neurology. 201: 416-27. PMID 16793040 DOI: 10.1016/J.Expneurol.2006.04.031  0.787
2005 Benveniste M, Dingledine R. Limiting stroke-induced damage by targeting an acid channel. The New England Journal of Medicine. 352: 85-6. PMID 15635119 DOI: 10.1056/Nejmcibr045010  0.599
2004 Liu Y, Ciliax BJ, Borges K, Dasigi V, Ram A, Navathe SB, Dingledine R. Comparison of two schemes for automatic keyword extraction from MEDLINE for functional gene clustering. Proceedings / Ieee Computational Systems Bioinformatics Conference, Csb. Ieee Computational Systems Bioinformatics Conference. 394-404. PMID 16448032 DOI: 10.1109/CSB.2004.1332452  0.435
2004 Doherty JJ, Alagarsamy S, Bough KJ, Conn PJ, Dingledine R, Mott DD. Metabotropic glutamate receptors modulate feedback inhibition in a developmentally regulated manner in rat dentate gyrus. The Journal of Physiology. 561: 395-401. PMID 15513941 DOI: 10.1113/jphysiol.2004.074930  0.795
2004 Laezza F, Dingledine R. Voltage-controlled plasticity at GluR2-deficient synapses onto hippocampal interneurons. Journal of Neurophysiology. 92: 3575-81. PMID 15331617 DOI: 10.1152/Jn.00425.2004  0.696
2004 Borges K, McDermott DL, Dingledine R. Reciprocal changes of CD44 and GAP-43 expression in the dentate gyrus inner molecular layer after status epilepticus in mice. Experimental Neurology. 188: 1-10. PMID 15191797 DOI: 10.1016/J.Expneurol.2004.03.019  0.558
2004 Bough KJ, Mott DD, Dingledine RJ. Medial perforant path inhibition mediated by mGluR7 is reduced after status epilepticus. Journal of Neurophysiology. 92: 1549-57. PMID 15152022 DOI: 10.1152/jn.00315.2004  0.807
2004 Myers SJ, Huang Y, Genetta T, Dingledine R. Inhibition of glutamate receptor 2 translation by a polymorphic repeat sequence in the 5'-untranslated leaders. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3489-99. PMID 15071096 DOI: 10.1523/Jneurosci.4127-03.2004  0.649
2003 Mott DD, Dingledine R. Interneuron Diversity series: Interneuron research--challenges and strategies. Trends in Neurosciences. 26: 484-8. PMID 12948659 DOI: 10.1016/S0166-2236(03)00200-5  0.495
2003 Borges K, Myers SJ, Zhang S, Dingledine R. Activity of the rat GluR4 promoter in transfected cortical neurons and glia. Journal of Neurochemistry. 86: 1162-73. PMID 12911624 DOI: 10.1046/J.1471-4159.2003.01926.X  0.592
2003 Borges K, Gearing M, McDermott DL, Smith AB, Almonte AG, Wainer BH, Dingledine R. Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Experimental Neurology. 182: 21-34. PMID 12821374 DOI: 10.1016/S0014-4886(03)00086-4  0.79
2003 Mott DD, Washburn MS, Zhang S, Dingledine RJ. Subunit-dependent modulation of kainate receptors by extracellular protons and polyamines. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 1179-88. PMID 12598606  0.569
2003 Doherty J, Dingledine R. Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system. Current Opinion in Pharmacology. 3: 46-53. PMID 12550741 DOI: 10.1016/S1471-4892(02)00014-0  0.649
2002 Doherty J, Dingledine R. The roles of metabotropic glutamate receptors in seizures and epilepsy. Current Drug Targets. Cns and Neurological Disorders. 1: 251-60. PMID 12769618 DOI: 10.2174/1568007023339355  0.635
2002 Maccaferri G, Dingledine R. Complex effects of CNQX on CA1 interneurons of the developing rat hippocampus. Neuropharmacology. 43: 523-9. PMID 12367599 DOI: 10.1016/S0028-3908(02)00161-2  0.77
2002 Huang Y, Doherty JJ, Dingledine R. Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 8422-8. PMID 12351716 DOI: 10.1523/Jneurosci.22-19-08422.2002  0.765
2002 Maccaferri G, Dingledine R. Control of feedforward dendritic inhibition by NMDA receptor-dependent spike timing in hippocampal interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 5462-72. PMID 12097498 DOI: 10.1523/Jneurosci.22-13-05462.2002  0.774
2001 Roopra A, Huang Y, Dingledine R. Neurological disease: listening to gene silencers. Molecular Interventions. 1: 219-28. PMID 14993344  0.622
2001 Borges K, Dingledine R. Functional organization of the GluR1 glutamate receptor promoter. The Journal of Biological Chemistry. 276: 25929-38. PMID 11340067 DOI: 10.1074/Jbc.M009105200  0.61
2001 Doherty J, Dingledine R. Reduced excitatory drive onto interneurons in the dentate gyrus after status epilepticus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 2048-57. PMID 11245688 DOI: 10.1523/Jneurosci.21-06-02048.2001  0.645
2000 Dingledine R, Conn PJ. Peripheral glutamate receptors: molecular biology and role in taste sensation. The Journal of Nutrition. 130: 1039S-42S. PMID 10736377 DOI: 10.1093/Jn/130.4.1039S  0.435
2000 Dingledine R, Doherty J. Genomics and epilepsy research in the new millenium Acta Neurologica Scandinavica, Supplement. 102: 9-10. DOI: 10.1034/J.1600-0404.2000.00202-4.X  0.548
1999 Huang Y, Myers SJ, Dingledine R. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nature Neuroscience. 2: 867-72. PMID 10491605 DOI: 10.1038/13165  0.611
1999 Laezza F, Doherty JJ, Dingledine R. Long-term depression in hippocampal interneurons: joint requirement for pre- and postsynaptic events. Science (New York, N.Y.). 285: 1411-4. PMID 10464102 DOI: 10.1126/Science.285.5432.1411  0.773
1999 Myers SJ, Dingledine R, Borges K. Genetic regulation of glutamate receptor ion channels. Annual Review of Pharmacology and Toxicology. 39: 221-41. PMID 10331083 DOI: 10.1146/Annurev.Pharmtox.39.1.221  0.662
1999 Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacological Reviews. 51: 7-61. PMID 10049997  0.657
1998 Mott DD, Doherty JJ, Zhang S, Washburn MS, Fendley MJ, Lyuboslavsky P, Traynelis SF, Dingledine R. Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition. Nature Neuroscience. 1: 659-67. PMID 10196581 DOI: 10.1038/3661  0.789
1998 Borges K, Dingledine R. AMPA receptors: molecular and functional diversity. Progress in Brain Research. 116: 153-70. PMID 9932376 DOI: 10.1016/S0079-6123(08)60436-7  0.657
1998 Myers SJ, Peters J, Huang Y, Comer MB, Barthel F, Dingledine R. Transcriptional regulation of the GluR2 gene: neural-specific expression, multiple promoters, and regulatory elements. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 6723-39. PMID 9712644 DOI: 10.1523/Jneurosci.18-17-06723.1998  0.648
1998 Doherty J, Dingledine R. Differential regulation of synaptic inputs to dentate hilar border interneurons by metabotropic glutamate receptors. Journal of Neurophysiology. 79: 2903-10. PMID 9636096 DOI: 10.1152/Jn.1998.79.6.2903  0.636
1998 Myers SJ, Peters J, Huang Y, Comer MB, Barthel F, Dingledine R. Transcriptional Regulation of the GluR2 Gene: Neural-Specific Expression, Multiple Promoters, and Regulatory Elements The Journal of Neuroscience. 18: 6723-6739. DOI: 10.1523/JNEUROSCI.18-17-06723.1998  0.55
1997 Washburn MS, Numberger M, Zhang S, Dingledine R. Differential dependence on GluR2 expression of three characteristic features of AMPA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 9393-406. PMID 9390995 DOI: 10.1523/Jneurosci.17-24-09393.1997  0.444
1997 Doherty J, Dingledine R. Regulation of excitatory input to inhibitory interneurons of the dentate gyrus during hypoxia. Journal of Neurophysiology. 77: 393-404. PMID 9120580 DOI: 10.1152/Jn.1997.77.1.393  0.659
1996 Washburn MS, Dingledine R. Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins. The Journal of Pharmacology and Experimental Therapeutics. 278: 669-78. PMID 8768718  0.347
1995 Bennett JA, Dingledine R. Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining reentrant membrane loop. Neuron. 14: 373-84. PMID 7857646 DOI: 10.1016/0896-6273(95)90293-7  0.503
1995 Kneisler TB, Dingledine R. Spontaneous and synaptic input from granule cells and the perforant path to dentate basket cells in the rat hippocampus. Hippocampus. 5: 151-64. PMID 7550611 DOI: 10.1002/hipo.450050302  0.8
1995 Kneisler TB, Dingledine R. Synaptic input from CA3 pyramidal cells to dentate basket cells in rat hippocampus. The Journal of Physiology. 487: 125-46. PMID 7473243 DOI: 10.1113/jphysiol.1995.sp020866  0.781
1993 Kawajiri S, Dingledine R. Multiple structural determinants of voltage-dependent magnesium block in recombinant NMDA receptors. Neuropharmacology. 32: 1203-11. PMID 8107974 DOI: 10.1016/0028-3908(93)90014-T  0.368
1993 McBain CJ, Dingledine R. Heterogeneity of synaptic glutamate receptors on CA3 stratum radiatum interneurones of rat hippocampus. The Journal of Physiology. 462: 373-92. PMID 8101227 DOI: 10.1113/jphysiol.1993.sp019560  0.718
1992 Curras MC, Dingledine R. Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Molecular Pharmacology. 41: 520-6. PMID 1372086  0.797
1992 McBain CJ, Eaton JV, Brown T, Dingledine R. CNQX increases spontaneous inhibitory input to CA3 pyramidal neurones in neonatal rat hippocampal slices. Brain Research. 592: 255-60. PMID 1360312 DOI: 10.1016/0006-8993(92)91683-6  0.739
1992 Dingledine R, Hume RI, Heinemann SF. Structural determinants of barium permeation and rectification in non-NMDA glutamate receptor channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 4080-7. PMID 1357118 DOI: 10.1523/Jneurosci.12-10-04080.1992  0.777
1992 McBain C, Dingledine R. Dual-component miniature excitatory synaptic currents in rat hippocampal CA3 pyramidal neurons. Journal of Neurophysiology. 68: 16-27. PMID 1355525  0.708
1992 Boulter J, Bettler B, Dingledine R, Edgebjerg J, Hartley M, Hermans-Borgmeyer I, Hollmann M, Hume RI, Rogers S, Heinemann S. Molecular biology of the glutamate receptors. Clinical Neuropharmacology. 15: 60A-61A. PMID 1323407 DOI: 10.1097/00002826-199201001-00033  0.393
1991 Boland LM, Allen AC, Dingledine R. Inhibition by bradykinin of voltage-activated barium current in a rat dorsal root ganglion cell line: role of protein kinase C. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 1140-9. PMID 2010809 DOI: 10.1523/Jneurosci.11-04-01140.1991  0.592
1991 Boland LM, Brown TA, Dingledine R. Gadolinium block of calcium channels: influence of bicarbonate. Brain Research. 563: 142-50. PMID 1786527 DOI: 10.1016/0006-8993(91)91527-8  0.598
1991 Dingledine R. New wave of non-NMDA excitatory amino acid receptors. Trends in Pharmacological Sciences. 12: 360-2. PMID 1662419 DOI: 10.1016/0165-6147(91)90602-O  0.35
1991 Dingledine R, Kleckner NW, McBain CJ. Excitatory amino acid receptors in the Xenopus oocyte expression system. Advances in Experimental Medicine and Biology. 287: 441-53. PMID 1662015 DOI: 10.1007/978-1-4684-5907-4_39  0.808
1991 Hume RI, Dingledine R, Heinemann SF. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science (New York, N.Y.). 253: 1028-31. PMID 1653450 DOI: 10.1126/Science.1653450  0.788
1990 McBain CJ, Traynelis SF, Dingledine R. Regional variation of extracellular space in the hippocampus. Science (New York, N.Y.). 249: 674-7. PMID 2382142 DOI: 10.1126/Science.2382142  0.751
1990 Dingledine R, McBain CJ, McNamara JO. Excitatory amino acid receptors in epilepsy. Trends in Pharmacological Sciences. 11: 334-8. PMID 2168104 DOI: 10.1016/0165-6147(90)90238-4  0.779
1990 Dingledine R, Myers SJ, Nicholas RA. Molecular biology of mammalian amino acid receptors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 4: 2636-45. PMID 2161372 DOI: 10.1096/Fasebj.4.9.2161372  0.413
1990 Kawasaki K, Traynelis SF, Dingledine R. Different responses of CA1 and CA3 regions to hypoxia in rat hippocampal slice. Journal of Neurophysiology. 63: 385-94. PMID 2158521 DOI: 10.1152/Jn.1990.63.3.385  0.569
1990 Boland LM, Dingledine R. Multiple components of both transient and sustained barium currents in a rat dorsal root ganglion cell line. The Journal of Physiology. 420: 223-45. PMID 2157839 DOI: 10.1113/jphysiol.1990.sp017909  0.581
1990 Dingledine R, Kleckner NW, McBain CJ. The glycine coagonist site of the NMDA receptor. Advances in Experimental Medicine and Biology. 268: 17-26. PMID 2150150 DOI: 10.1007/978-1-4684-5769-8_3  0.801
1990 McNamara D, Smith EC, Calligaro DO, O'Malley PJ, McQuaid LA, Dingledine R. 5,7-Dichlorokynurenic acid, a potent and selective competitive antagonist of the glycine site on NMDA receptors. Neuroscience Letters. 120: 17-20. PMID 2149877 DOI: 10.1016/0304-3940(90)90157-5  0.423
1990 McNamara D, Dingledine R. Dual effect of glycine on NMDA-induced neurotoxicity in rat cortical cultures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 3970-6. PMID 1980134 DOI: 10.1523/Jneurosci.10-12-03970.1990  0.365
1990 Dawson TL, Nicholas RA, Dingledine R. Homomeric GluR1 excitatory amino acid receptors expressed in Xenopus oocytes. Molecular Pharmacology. 38: 779-84. PMID 1979144  0.325
1990 Chamberlin NL, Traub RD, Dingledine R. Role of EPSPs in initiation of spontaneous synchronized burst firing in rat hippocampal neurons bathed in high potassium. Journal of Neurophysiology. 64: 1000-8. PMID 1977893 DOI: 10.1152/Jn.1990.64.3.1000  0.354
1990 Boland LM, Dingledine R. Expression of sensory neuron antigens by a dorsal root ganglion cell line, F-11. Brain Research. Developmental Brain Research. 51: 259-66. PMID 1969775 DOI: 10.1016/0165-3806(90)90284-6  0.569
1990 Kawasaki K, Traynelis SF, Dingledine R. Epilepsy, human and experimentalHypoxia-induced different responses in CA1 and CA3 regions of the rat hippocampal slice Neuroscience Research Supplements. 11. DOI: 10.1016/0921-8696(90)90589-U  0.542
1990 Kawasaki K, Traynelis SF, Dingledine R. Hypoxia-induced different responses in CA1 and CA3 regions of the rat hippocampal slice Neuroscience Research Supplements. 15: S45. DOI: 10.1016/0921-8696(90)90166-Z  0.529
1990 McBain CJ, Traynelis SF, Dingledine R. The volume fraction of rat hippocampal extracellular space in vitro displays marked subfield variation Journal of Physiology. 426: 49P.  0.71
1989 Traynelis SF, Dingledine R. Role of extracellular space in hyperosmotic suppression of potassium-induced electrographic seizures. Journal of Neurophysiology. 61: 927-38. PMID 2723735 DOI: 10.1152/Jn.1989.61.5.927  0.568
1989 Traynelis SF, Dingledine R, McNamara JO, Butler L, Rigsbee L. Effect of kindling on potassium-induced electrographic seizures in vitro. Neuroscience Letters. 105: 326-32. PMID 2594218 DOI: 10.1016/0304-3940(89)90642-3  0.66
1989 Traynelis SF, Dingledine R. Modification of potassium-induced interictal bursts and electrographic seizures by divalent cations. Neuroscience Letters. 98: 194-9. PMID 2565567 DOI: 10.1016/0304-3940(89)90509-0  0.583
1989 Verdoorn TA, Kleckner NW, Dingledine R. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology. Molecular Pharmacology. 35: 360-8. PMID 2564633  0.723
1989 McBain CJ, Kleckner NW, Wyrick S, Dingledine R. Structural requirements for activation of the glycine coagonist site of N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Molecular Pharmacology. 36: 556-65. PMID 2554111  0.671
1989 Kleckner NW, Dingledine R. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors. Molecular Pharmacology. 36: 430-6. PMID 2550776  0.346
1989 Ferkany JW, Kyle DJ, Willets J, Rzeszotarski WJ, Guzewska ME, Ellenberger SR, Jones SM, Sacaan AI, Snell LD, Borosky S, Jones BE, Johnson KM, Balster RL, Burchett K, Kawasaki K, ... ... Dingledine R, et al. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist Journal of Pharmacology and Experimental Therapeutics. 250: 100-109. PMID 2545856  0.304
1988 Chamberlin NL, Dingledine R. GABAergic inhibition and the induction of spontaneous epileptiform activity by low chloride and high potassium in the hippocampal slice. Brain Research. 445: 12-8. PMID 3365550 DOI: 10.1016/0006-8993(88)91068-2  0.307
1988 Traynelis SF, Dingledine R. Potassium-induced spontaneous electrographic seizures in the rat hippocampal slice. Journal of Neurophysiology. 59: 259-76. PMID 3343603 DOI: 10.1152/Jn.1988.59.1.259  0.569
1988 Verdoorn TA, Dingledine R. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology. Molecular Pharmacology. 34: 298-307. PMID 2901662  0.725
1988 Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science (New York, N.Y.). 241: 835-7. PMID 2841759 DOI: 10.1126/Science.2841759  0.687
1988 Dingledine R, Boland LM, Chamberlin NL, Kawasaki K, Kleckner NW, Traynelis SF, Verdoorn TA. Amino acid receptors and uptake systems in the mammalian central nervous system. Critical Reviews in Neurobiology. 4: 1-96. PMID 2461808  0.82
1988 Berry BW, Boland LM, Hoch DB, Dingledine R. L-glutamate binding site on N18-RE-105 neuroblastoma hybrid cells is not coupled to an ion channel. Journal of Neurochemistry. 51: 1176-83. PMID 2458433 DOI: 10.1111/j.1471-4159.1988.tb03084.x  0.631
1987 Korn SJ, Giacchino JL, Chamberlin NL, Dingledine R. Epileptiform burst activity induced by potassium in the hippocampus and its regulation by GABA-mediated inhibition. Journal of Neurophysiology. 57: 325-40. PMID 3559679 DOI: 10.1152/Jn.1987.57.1.325  0.803
1987 Dingledine R, Roth AA, King GL. Synaptic control of pyramidal cell activation in the hippocampal slice preparation in the rat. Neuroscience. 22: 553-61. PMID 3313098 DOI: 10.1016/0306-4522(87)90352-6  0.335
1987 Verdoorn TA, Kleckner NW, Dingledine R. Rat brain N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Science (New York, N.Y.). 238: 1114-6. PMID 2825347 DOI: 10.1126/Science.2825347  0.818
1986 Korn SJ, Dingledine R. Prolongation of gamma-aminobutyric acid-mediated inhibitory postsynaptic potentials by 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol (THPO). Neuroscience Letters. 64: 47-52. PMID 3960387 DOI: 10.1016/0304-3940(86)90661-0  0.654
1986 Korn SJ, Dingledine R. Inhibition of GABA uptake in the rat hippocampal slice. Brain Research. 368: 247-55. PMID 3697725 DOI: 10.1016/0006-8993(86)90569-X  0.671
1986 Hoch DB, Dingledine R. GABAergic neurons in rat hippocampal culture. Brain Research. 390: 53-64. PMID 3512041 DOI: 10.1016/0165-3806(86)90151-3  0.328
1986 Dingledine R, Hynes MA, King GL. Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. The Journal of Physiology. 380: 175-89. PMID 2886653 DOI: 10.1113/jphysiol.1986.sp016279  0.417
1986 King GL, Dingledine R. Evidence for the activation of the N-methyl-D-aspartate receptor during epileptiform discharge. Advances in Experimental Medicine and Biology. 203: 465-74. PMID 2878569 DOI: 10.1007/978-1-4684-7971-3_35  0.374
1986 Dingledine R. NMDA Receptors: what do they do? Trends in Neurosciences. 9: 47-49. DOI: 10.1016/0166-2236(86)90017-2  0.455
1985 King GL, Dingledine R, Giacchino JL, McNamara JO. Abnormal neuronal excitability in hippocampal slices from kindled rats. Journal of Neurophysiology. 54: 1295-304. PMID 3001236 DOI: 10.1152/Jn.1985.54.5.1295  0.763
1985 King GL, Knox JJ, Dingledine R. Reduction of inhibition by a benzodiazepine antagonist, Ro15-1788, in the rat hippocampal slice. Neuroscience. 15: 371-8. PMID 2991811 DOI: 10.1016/0306-4522(85)90219-2  0.405
1985 Dingledine R, Korn SJ. Gamma-aminobutyric acid uptake and the termination of inhibitory synaptic potentials in the rat hippocampal slice. The Journal of Physiology. 366: 387-409. PMID 2414435 DOI: 10.1113/jphysiol.1985.sp015804  0.647
1983 Dingledine R, Valentino RJ, Bostock E, King ME, Chang KJ. Down-regulation of delta but not mu opioid receptors in the hippocampal slice associated with loss of physiological response. Life Sciences. 33: 333-6. PMID 6319888 DOI: 10.1016/0024-3205(83)90510-6  0.617
1983 Dingledine R. N-methyl aspartate activates voltage-dependent calcium conductance in rat hippocampal pyramidal cells. The Journal of Physiology. 343: 385-405. PMID 6139475 DOI: 10.1113/jphysiol.1983.sp014899  0.349
1982 Valentino RJ, Dingledine R. Pharmacological characterization of opioid effects in the rat hippocampal slice. The Journal of Pharmacology and Experimental Therapeutics. 223: 502-9. PMID 6752374  0.505
1982 Valentino RJ, Bostock E, Dingledine R. Opioid pharmacology in the rat hippocampal slice. Life Sciences. 31: 2339-42. PMID 6131361 DOI: 10.1016/0024-3205(82)90151-5  0.584
1981 Dingledine R. Possible mechanisms of enkephalin action on hippocampal CA1 pyramidal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 1: 1022-35. PMID 7026738 DOI: 10.1523/Jneurosci.01-09-01022.1981  0.347
1981 Valentino RJ, Dingledine R. Presynaptic inhibitory effect of acetylcholine in the hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 1: 784-92. PMID 6286902 DOI: 10.1523/Jneurosci.01-07-00784.1981  0.579
1981 Dodd J, Dingledine R, Kelly JS. The excitatory action of acetylcholine on hippocampal neurones of the guinea pig and rat maintained in vitro. Brain Research. 207: 109-27. PMID 6258725 DOI: 10.1016/0006-8993(81)90682-X  0.51
1980 Andersen P, Dingledine R, Gjerstad L, Langmoen IA, Laursen AM. Two different responses of hippocampal pyramidal cells to application of gamma-amino butyric acid. The Journal of Physiology. 305: 279-96. PMID 7441554 DOI: 10.1113/jphysiol.1980.sp013363  0.507
1980 Dingledine R, Langmoen IA. Conductance changes and inhibitory actions of hippocampal recurrent IPSPs. Brain Research. 185: 277-87. PMID 7357430 DOI: 10.1016/0006-8993(80)91068-9  0.336
1980 Dingledine R, Dodd J, Kelly JS. The in vitro brain slice as a useful neurophysiological preparation for intracellular recording. Journal of Neuroscience Methods. 2: 323-62. PMID 6106092 DOI: 10.1016/0165-0270(80)90002-3  0.477
1979 Dingledine R, Gjerstad L. Penicillin blocks hippocampal IPSPs, unmasking prolonged EPSPs. Brain Research. 168: 205-9. PMID 455081 DOI: 10.1016/0006-8993(79)90141-0  0.341
1979 Kelly JS, Dodd J, Dingledine R. Acetylcholine as an excitatory and inhibitory transmitter in the mammalian central nervous system. Progress in Brain Research. 49: 253-66. PMID 229514 DOI: 10.1016/S0079-6123(08)64638-5  0.529
1978 Dingledine R, Iversen LL, Breuker E. Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. European Journal of Pharmacology. 47: 19-27. PMID 618728 DOI: 10.1016/0014-2999(78)90369-2  0.377
1977 Dingledine R, Kelly JS. Brain stem stimulation and the acetylcholine-evoked inhibition of neurones in the feline nucleus reticularis thalami. The Journal of Physiology. 271: 135-54. PMID 915830 DOI: 10.1113/jphysiol.1977.sp011994  0.5
1977 Dingledine R, Dodd J, Kelly JS. Intracellular recording from pyramidal neurones in the in vitro transverse hippocampal slice [proceedings]. The Journal of Physiology. 269: 13P-15P. PMID 894533  0.434
1977 Ross M, Dingledine R, Cox BM, Goldstein A. Distribution of endorphins (peptides with morphine-like pharmacological activity) in pituitary. Brain Research. 124: 523-32. PMID 851863 DOI: 10.1016/0006-8993(77)90951-9  0.65
1977 Dingledine R, Kelly JS. Midbrain reticular evoked inhibition of thalamic neurones [proceedings]. The Journal of Physiology. 265: 46P-47P. PMID 850185  0.4
1977 Dingledine R, Dodd J, Kelly JS. Ach-evoked excitation of cortical neurones [proceedings]. The Journal of Physiology. 273: 79P-80P. PMID 599477  0.387
1976 Ben-Ari Y, Dingledine R, Kanazawa I, Kelly JS. Inhibitory effects of acetylcholine on neurones in the feline nucleus reticularis thalami. The Journal of Physiology. 261: 647-71. PMID 978591 DOI: 10.1113/jphysiol.1976.sp011579  0.434
1976 Iversen L, Dingledine R. Enkephalin: the latest instalment Nature. 262: 738-739. DOI: 10.1038/262738a0  0.621
1975 Dingledine R, Goldstein A. Single neuron studies of opiate action in the guinea pig myenteric plexus. Life Sciences. 17: 57-62. PMID 1143011 DOI: 10.1016/0024-3205(75)90235-0  0.575
1974 Dingledine R, Goldstein A, Kendig J. Effects of narcotic opiates and serotonin on the electrical behavior of neurons in the guinea pig myenteric plexus. Life Sciences. 14: 2299-309. PMID 4847817 DOI: 10.1016/0024-3205(74)90111-8  0.561
1973 Dingledine R, Goldstein A. Lethality of the morphinan isomers levorphanol and dextrorphan. British Journal of Pharmacology. 48: 718-20. PMID 4788214 DOI: 10.1111/j.1476-5381.1973.tb08261.x  0.514
Show low-probability matches.